Sepio Capital’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.89M | Buy |
27,391
+32
| +0.1% | +$2.21K | 0.13% | 107 |
|
2025
Q1 | $1.9M | Buy |
27,359
+7,455
| +37% | +$518K | 0.15% | 108 |
|
2024
Q4 | $1.71M | Sell |
19,904
-138
| -0.7% | -$11.9K | 0.14% | 119 |
|
2024
Q3 | $2.39M | Sell |
20,042
-154
| -0.8% | -$18.3K | 0.19% | 98 |
|
2024
Q2 | $2.88M | Sell |
20,196
-78
| -0.4% | -$11.1K | 0.26% | 79 |
|
2024
Q1 | $2.6M | Sell |
20,274
-1,970
| -9% | -$253K | 0.22% | 92 |
|
2023
Q4 | $2.3M | Sell |
22,244
-3,461
| -13% | -$358K | 0.19% | 95 |
|
2023
Q3 | $2.34M | Buy |
25,705
+319
| +1% | +$29K | 0.2% | 103 |
|
2023
Q2 | $2.05M | Sell |
25,386
-1,016
| -4% | -$82.2K | 0.17% | 143 |
|
2023
Q1 | $2.1M | Sell |
26,402
-4,054
| -13% | -$323K | 0.19% | 137 |
|
2022
Q4 | $2.06M | Sell |
30,456
-4,628
| -13% | -$313K | 0.18% | 147 |
|
2022
Q3 | $1.75M | Sell |
35,084
-1,404
| -4% | -$70K | 0.17% | 143 |
|
2022
Q2 | $2.03M | Sell |
36,488
-1,204
| -3% | -$67.1K | 0.2% | 138 |
|
2022
Q1 | $2.09M | Sell |
37,692
-2,666
| -7% | -$148K | 0.18% | 151 |
|
2021
Q4 | $2.26M | Buy |
40,358
+92
| +0.2% | +$5.15K | 0.17% | 159 |
|
2021
Q3 | $1.93M | Buy |
40,266
+188
| +0.5% | +$9.03K | 0.16% | 169 |
|
2021
Q2 | $1.68M | Sell |
40,078
-4,590
| -10% | -$192K | 0.14% | 184 |
|
2021
Q1 | $1.51M | Buy |
+44,668
| New | +$1.51M | 0.14% | 180 |
|
2019
Q3 | – | Sell |
-143,208
| Closed | -$3.66M | – | 269 |
|
2019
Q2 | $3.66M | Sell |
143,208
-704
| -0.5% | -$18K | 0.49% | 61 |
|
2019
Q1 | $3.76M | Sell |
143,912
-19,720
| -12% | -$516K | 0.51% | 55 |
|
2018
Q4 | $3.77M | Buy |
+163,632
| New | +$3.77M | 0.27% | 66 |
|